Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Disgraced pharmacist faces prison time over COVID-19 vaccine tampering charges

By Brian Buntz | February 11, 2021

Steven Brandenburg

Steven Brandenburg

A Wisconsin pharmacist who allegedly spoiled 57 vials of Moderna (NSDQ:MRNA) pleaded guilty to two federal counts of consumer product tampering. Each vial contains 10 vaccine doses. 

The pharmacist Steven Brandenburg, who recently had his license revoked, is accused of deliberately removing the vials from refrigeration for several hours before the vaccine was administered to 57 people. 

Brandenburg entertained conspiracy theories about the vaccine, according to federal court filings. The documents state that Brandenburg believed the Moderna vaccine contained microchips, caused DNA mutations and could cause infertility. He also apparently believes the earth is flat. 

Brandenburg also allegedly brought guns to his former workplace at Advocate Aurora Health in Grafton, Wis. and was involved in substituting flu vaccines with saline. 

U.S. District Judge Brett Ludwig in Milwaukee scheduled a sentencing hearing for June 8.

If convicted, Brandenburg could face up to four years and three months of jail time and $500,000 in fines. 

Ludwig ordered Brandenburg to have a mental health evaluation and to wear a GPS monitor until sentencing. 

Brandenburg is also facing a state misdemeanor charge for attempted criminal damage to property. 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

Rendering of Eli Lilly facility in Lehigh Valley, PA (1)
Lilly to build $3.5B injectable medicine, device manufacturing plant in Pennsylvania
Antheia_Logo (1)
Antheia closes $80M financing to strengthen U.S. drug manufacturing
This is the logo of Abbvie.
AbbVie acquires drug delivery manufacturing plant in Arizona
Apiject Logo
Apiject to open new injectable drug manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE